IQVIA Holdings has significantly outperformed the broader S&P 500 Index in recent months, and analysts remain strongly ...

Over the last decade, the number of cell and gene therapy clinical trials has more than tripled. In this article, several ...

If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want ...

IQVIA , a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic ...

IQVIA and AWS said the collaboration reflects the growing need for cloud-based tools that can support large-scale trial ...

With new UK clinical trial rules landing in 2026, the EU Biotech Act on the horizon and China and Australia gaining ground, ...

Biotech and pharma greenhouse gas emissions are falling – but is current progress fast enough? Discover My Green Lab’s Impact ...

The Life Sciences BPO Market is expanding rapidly, driven by rising R&D costs, increasing regulatory complexities and the growing need for operational efficiency across pharma and biotech sectors.

CDMOs have become structural pillars of drug development, keeping pipelines moving, absorbing operational shocks, and turning ...

RFID-enabled, temperature-controlled cabinets represent a critical advancement for hospital and health system pharmacies, ...

Meg Hooton, President of IQVIA Biotech, leads the organisation, providing clinical development solutions for biotech and emerging biopharma clients. With over 30 years of global R&D and operational ...

Q2 2026 Earnings Call Transcript December 4, 2025 John Wiley & Sons, Inc. beats earnings expectations. Reported EPS is $1.1, ...